Immunosuppression Modification by Everolimus With Minimization of Calcineurin Inhibitors Recovers Kidney Graft Function Even in Patients With Very Late Conversion and Also With Poor Graft Function
Author:
Publisher
Elsevier BV
Subject
Transplantation,Surgery
Reference8 articles.
1. Clinical renal transplantation: where are we now, what are our key challenges?;Chapman;Transplant Proc,2010
2. Everolimus and mycophenolate mofetil are potent inhibitors of fibroblast proliferation after lung transplantation;Azzola;Transplantation,2004
3. Everolimus and long-term outcomes in renal transplantation;Campistol;Transplantation,2011
4. Everolimus plus early tacrolimus minimization: a phase III, randomized, open-label, multicentre trial in renal transplantation;Langer;Transpl Int,2012
5. Chronic renal allograft dysfunction;Chapman;J Am Soc Nephrol,2005
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Safety and effectiveness of everolimus in maintenance kidney transplant patients in the real-world setting: results from a 2-year post-marketing surveillance study in Japan;Clinical and Experimental Nephrology;2021-02-11
2. Effect of Everolimus with Low-Dose Tacrolimus on Development of New-Onset Diabetes After Transplantation and Allograft Function in Kidney Transplantation: A Multicenter, Open-Label, Randomized Trial;Annals of Transplantation;2021-01-22
3. META-ANALYSIS OF THE EFFICACY OF BAILING CAPSULE IN THE TREATMENT OF CHRONIC ALLOGRAFT NEPHROPATHY;ACTA MEDICA MEDITERR;2020
4. Introduction of everolimus in kidney transplant recipients at a late posttransplant stage;World Journal of Transplantation;2018-09-10
5. Drugs That Act on the Immune System: Immunosuppressive and Immunostimulatory Drugs;Side Effects of Drugs Annual;2018
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3